Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Accretion Nutraveda Ltd

BSE: 544694 · Pharmaceuticals & Biotechnology · 12 announcements

Share price
₹304.50
Market cap
₹220.5 Cr
Revenue (annual)
₹33.60 Cr
Net profit (annual)
₹5.07 Cr
P/E (TTM)
43.5×Sector 47.4×
Promoter holding
73.48%+0.00% QoQ
FII holding
1.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:18 IST BSE
Other Announcement

Accretion Nutraveda Other Announcement

Accretion Nutraveda Limited informed shareholders of the weblink to access the FY 2025-26 Annual Report and notice for the 5th Annual General Meeting.

16:50 IST BSE
Other Announcement

Accretion Nutraveda Other Announcement

Accretion Nutraveda Limited confirmed it does not fall under the 'Large Corporate' category for FY 2026-2027. Consequently, SEBI's initial disclosure requirements for fund raising by issuance of debt securities are not applicable to the company.